IKBKB could be activated by α-KG produced by GDH1 and then upregulate GLUT1 to promote glucose uptake and tumor cell survival, thus accelerating the occurrence of glioma (Wang et al., 2019). This evidence concerns the gene SLC2A1 and glioma.